Granulomatosis with Polyangiitis
📧 Sign up to get email alerts when something new happens for Granulomatosis with Polyangiitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases [Phase 4]
Phase 4 clinical trial assessing safety and immunogenicity of the live attenuated tetravalent Butantan-Dengue vaccine in autoimmune rheumati…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis [Phase 3]
This clinical trial update describes a Phase 3 study evaluating salvage therapy for granulomatosis with polyangiitis (ANCA-associated vascul…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis [Phase 2]
A Phase 2 clinical trial evaluating obinutuzumab as induction therapy for remission in relapsing PR3-ANCA granulomatosis with polyangiitis i…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis. [Phase 4]
A Phase 4 clinical trial comparing clinico-biological monitoring to pre-emptive rituximab for ANCA reappearance in granulomatosis with polya…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA [Phase 2]
A Phase 2 clinical trial is evaluating rapcabtagene autoleucel for severe active granulomatosis with polyangiitis and microscopic polyangiit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW) [Phase 3]
The SAFE-LOW Phase 3 trial evaluating low-dose glucocorticoids for ANCA-associated vasculitis is currently recruiting, focusing on granuloma…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Vasculitis Pregnancy Registry
Clinical trial update for a pregnancy registry in vasculitis sponsored by the University of Pennsylvania, currently recruiting to evaluate p…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
A clinical trial update for the CUTIS study, which is recruiting to study transcriptomics in systemic vasculitis conditions.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: VCRC Tissue Repository
The University of Pennsylvania–sponsored VCRC Tissue Repository trial is currently recruiting. It covers multiple forms of vasculitis.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) [Phase 1]
Phase 1 clinical trial update for SC291 in severe B-cell–mediated autoimmune diseases; the study is active but not recruiting and includes s…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis [Phase 1, Phase 2]
Clinical trial update for the TEMPO study evaluating trimethoprim-sulfamethoxazole in granulomatosis with polyangiitis, a Phase 1/2 study cu…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis. [NA]
A clinical trial is evaluating whether extended prednisone maintenance can sustain remission in granulomatosis with polyangiitis (ANCA-assoc…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Special Drug Use-results Survey for Long-term Use（Avacopan）
A long-term-use results survey for avacopan in microscopic polyangiitis and granulomatosis with polyangiitis is currently recruiting in a st…
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. [Phase 1]
Open-label Phase 1 study evaluating the safety and preliminary efficacy of combining Rituximab with AB-101 in B-cell–associated autoimmune d…
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: Journey of Patients With Vasculitis From First Symptom to Diagnosis
A completed University of Pennsylvania clinical study tracks vasculitis patients from first symptoms through diagnosis, describing the diagn…
-
CLINICAL_TRIALS research · 2016-08-19Clinical Trial Update: American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
This clinical trial update describes progress on the ACR/EULAR diagnostic and classification criteria for primary systemic vasculitis, spons…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Impact of Vasculitis on Employment and Income
This completed clinical trial update examines how vasculitis and its subtypes impact employment and income for patients.
-
CLINICAL_TRIALS research · 2015-05-28Clinical Trial Update: PRO Development for ANCA Associated Vasculitis
Clinical trial update describing the development of a patient-reported outcome measure for ANCA-associated vasculitis.
-
CLINICAL_TRIALS research · 2014-07-15Clinical Trial Update: Educational Needs of Patients With Systemic Vasculitis
The document reports on a completed clinical trial evaluating the educational needs and resources for patients with systemic vasculitis.
-
CLINICAL_TRIALS research · 2014-04-29Clinical Trial Update: Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
An observational study update on pulmonary vasculitis in Chinese patients, describing clinical manifestations and outcomes across ANCA-assoc…
-
CLINICAL_TRIALS research · 2008-09-12Clinical Trial Update: Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides [Phase 2]
Phase 2 trial comparing cyclophosphamide versus methotrexate for remission maintenance in systemic necrotizing vasculitides. The current tri…